Notice of Change in Expiration Date and Application Due Date for PAR-16-155 "NeuroNEXT Clinical Trials (U01)"

Notice Number: NOT-NS-17-034

Key Dates
Release Date: June 12, 2017

Related Announcements

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)


The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-16-155 "NeuroNEXT Clinical Trials (U01)" will be extended by one receipt cycle. An additional non-AIDS application due date of December 6, 2017 has been added for this FOA. This FOA expires on December 7, 2017.

The Key Dates table is updated accordingly:

Part 1. Overview Information

Key Dates

Application Due Date(s)

August 2, 2016; December 6, 2016; April 4, 2017; August 3, 2017; December 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

October, 2016; February, 2017; June, 2017; October, 2017; February 2018

Advisory Council Review

January, 2017; May 2017; October, 2017; January, 2018; May 2018

Earliest Start Date(s)

March, 2017; July, 2017; December, 2017; May, 2018; September 2018

Expiration Date

December 7, 2017

All other aspects of this FOA remain the same.


Please direct all inquiries to:

Codrin Lungu, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135